| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |